Residential location posed mass casualty risk; charges include narcotics and firearms offenses.
DEA New York Division Special Agent in Charge Farhana Islam announced that two men have been charged with narcotics and firearms offenses for operating a fentanyl manufacturing plant inside a residential building. The charges were filed in coordination with the U.S. Attorney's Office for the Southern District of New York. This enforcement action targets illegal fentanyl production infrastructure located within a populated residential area, reflecting continued federal efforts to disrupt domestic synthetic drug manufacturing operations.
Sources
DEA Charges 2 Men with Fentanyl Lab in NY Building
More from Healthcare Browse all →
CMS Proposes API Mandate for Healthcare Prior Authorization
CMS published two coordinated proposed rules requiring Medicare Advantage organizations, state Medicaid programs, and CHIP to implement electronic API-based prior authorization systems. The mandate aims to reduce administrative burden on healthcare providers and eliminate delays in patient care caused by paper-based authorization processes.
April 20, 2026
Texas Medical Board Restricts Three Licenses in 11 Days
The Texas Medical Board restricted three medical licenses in an 11-day period, including a surgical assistant arrested on aggravated sexual assault of a child charges and two physicians facing separate patient safety allegations. The rapid sequence suggests heightened enforcement activity at the board.
April 20, 2026
Canada Battles Dual Foodborne Illness Outbreaks in One Day
E. coli from Pizza Pops and Salmonella from pistachios sicken 184 across six provinces, with 31 hospitalized.
April 16, 2026
CMS Requires States to Cut Medicaid Coverage for Some Noncitizens
Federal guidance under Public Law 119-21 forces eligibility system changes affecting millions of vulnerable residents.
April 15, 2026
Get the briefing in your inbox
The top regulatory stories, delivered daily. No noise.
Free. Unsubscribe anytime.